Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Pernix Sleep, Inc.Listing unverified | Sell | $28.5K | SEC | ||
Pernix Sleep, Inc.Listing unverified | Sell | $23.3K | SEC | ||
Pernix Sleep, Inc.Listing unverified | Sell | $420.5 | SEC | ||
EPIRUS Biopharmaceuticals, Inc.Listing unverified | Sell | $437.8K | SEC | ||
EPIRUS Biopharmaceuticals, Inc.Listing unverified | Sell | $35.5K | SEC | ||
ARYx Therapeutics, Inc.Security delisted | BuyD (derivative) | $5K | ClusterFirst in 12mo | SEC | |
Altimmune, Inc.Listing on record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Altimmune, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Altimmune, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ReShape Weightloss Inc.Listing unverified | Buy | $2M | conv 48ClusterFirst in 12mo | SEC | |
ReShape Weightloss Inc.Listing unverified | BuyD (derivative) | $114.8K | ClusterFirst in 12mo | SEC | |
Altimmune, Inc.Listing on record | Buy | $962.5K | conv 35Cluster | SEC | |
Altimmune, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Altimmune, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Altimmune, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Altimmune, Inc.Listing on record | Buy | $962.5K | conv 35Cluster | SEC | |
Altimmune, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Altimmune, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
PONIARD PHARMACEUTICALS, INC.Listing on record | Buy | $5.7M | conv 41ClusterFirst in 12mo | SEC |